Rapid Neurological Decline Due to Creutzfeldt-Jakob Disease

Authors

Nicole Tesoro, Extern Program, MedStar Harbor HospitalFollow
David Blackwood, Department of Medicine, MedStar Harbor Hospital & Assistant Professor, Georgetown University School of MedicineFollow
Robert Reif, Department of Neurology, MedStar Harbor HospitalFollow
Samuel Miller, Department of Neurology, MedStar Harbor HospitalFollow
Kalyan Paudel, Department of Radiology, MedStar Harbor HospitalFollow
Christopher Haas, Associate Professor of Medicine, Georgetown University School of Medicine & Associate Program Director, MedStar Health Internal Medicine ProgramFollow

Abstract

Creutzfeldt-Jakob Disease (CJD) is an exceedingly rare condition with an incidence of one case per million people worldwide. It is diagnosed with symptoms of rapid neurological decline, positive CSF biomarkers, and diagnostic findings on MRI and EEG. There is no known effective therapy for CJD and prompt diagnosis is required to prepare for the expected disease prognosis and goals of care discussions.

Recommended Citation

Tesoro, Nicole; Blackwood, David; Reif, Robert; Miller, Samuel; Paudel, Kalyan; and Haas, Christopher () "Rapid Neurological Decline Due to Creutzfeldt-Jakob Disease," Journal of Community Hospital Internal Medicine Perspectives: Vol. 15: Iss. 1, Article 10.
DOI: 10.55729/2000-9666.1446
Available at: https://scholarlycommons.gbmc.org/jchimp/vol15/iss1/10